Corcept Therapeutics
CORT
#2411
Rank
A$9.46 B
Marketcap
$90.36
Share price
9.76%
Change (1 day)
129.64%
Change (1 year)

Corcept Therapeutics (CORT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$0.22 Billion

According to Corcept Therapeutics 's latest financial reports the company's total liabilities are A$0.22 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Corcept Therapeutics - Total liabilities on balance sheet (from 2003 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$0.16 B40.56%
2022-12-31A$0.11 B81.27%
2021-12-31A$66.13 M5.09%
2020-12-31A$62.93 M7.13%
2019-12-31A$58.74 M15.56%
2018-12-31A$50.83 M34.22%
2017-12-31A$37.87 M-0.27%
2016-12-31A$37.97 M-17.18%
2015-12-31A$45.85 M-1.29%
2014-12-31A$46.45 M-1.48%
2013-12-31A$47.15 M31.06%
2012-12-31A$35.97 M634%
2011-12-31A$4.9 M28.99%
2010-12-31A$3.8 M41.12%
2009-12-31A$2.69 M-33.76%
2008-12-31A$4.06 M18.07%
2007-12-31A$3.44 M-23.38%
2006-12-31A$4.49 M-7.73%
2005-12-31A$4.86 M106.59%
2004-12-31A$2.35 M-95.95%
2003-12-31A$58.19 M-25.04%
2002-12-31A$77.62 M2002.81%
2001-12-31A$3.69 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$163.94 B 74,255.32%๐Ÿ‡บ๐Ÿ‡ธ USA
A$115.94 B 52,484.89%๐Ÿ‡บ๐Ÿ‡ธ USA
A$91.09 B 41,216.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$92.91 B 42,043.69%๐Ÿ‡บ๐Ÿ‡ธ USA
A$194.39 B 88,069.60%๐Ÿ‡บ๐Ÿ‡ธ USA
A$104.58 B 47,335.74%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.05 B 378.98%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.01 B 360.46%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.17 B 888.71%๐Ÿ‡บ๐Ÿ‡ธ USA